Testing times for diagnostics firm UGenix as Covid demand drops
The medical technology company is looking to list in Hong Kong after a windfall from Covid testing, but its other screening services are not yet lucrative Key Takeaways: Covid tests…
Recent Articles
RELATED ARTICLES
-
Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
Airdoc Tech enjoys healing properties of medical AI rally
2251.HK
- Baige flies into IPO on demand for its popular – but costly – insurance risk services
- As Covid drug cash dwindles, Vigonvita targets new remedies
- Mixue pours up strong growth in China’s overheated bubble tea market
- IPO pitch puts BrainAurora’s earnings under the microscope
- Lemo massages its way to Hong Kong listing
